Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effect of Prewarming Duration on Blood Flow After Colon Resection Surgery

30. September 2026 aktualisiert von: Çiğdem Ünal Kantekin

Evaluation of the Effect of Preoperative Prewarming Duration on Postoperative Perfusion Index in Patients Undergoing Colon Resection Surgery: A Randomized Controlled Trial

This study will examine whether warming patients before colon resection surgery improves blood flow in the fingers during early recovery from general anesthesia. It will also compare two warming durations. A total of 108 adults scheduled for elective colon resection surgery at Kayseri City Hospital will be assigned by chance to one of three groups: 10 minutes of warming before anesthesia, 30 minutes of warming before anesthesia, or no active warming before anesthesia. All three groups will receive warming during surgery as part of routine care.

Warming will be provided using a forced-air warming system. After surgery, a sensor placed on a finger will measure the perfusion index, a noninvasive indicator of blood flow, on arrival in the recovery unit and 5 and 10 minutes later. The main comparison will use the average of these three measurements. The researchers will also assess other circulation measurements, routine blood gas and lactate results, shivering, pain, the time until oral feeding begins, and wound infection during the 14 days after surgery.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This prospective, single-center, randomized controlled study will be conducted by the Department of Anesthesiology and Reanimation at Kayseri City Hospital. Adults undergoing elective colon resection under general anesthesia will be randomized in a 1:1:1 ratio using a computer-generated randomization list. Allocation will be concealed in sequentially numbered, sealed opaque envelopes opened before the preoperative intervention. The planned sample size is 108 participants, with 36 participants per group.

Active prewarming will be applied in the preoperative preparation area using a forced-air warming system covering the upper and lower body. Device settings will follow manufacturer recommendations and institutional clinical standards. The two prewarming groups will receive 10 or 30 minutes of active warming before anesthesia. The control group will receive routine preoperative care without active prewarming. All groups will receive intraoperative warming and standard anesthesia monitoring and management.

Perfusion index and pleth variability index will be measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission and at 5 and 10 minutes. The primary analysis will compare the arithmetic mean of the three postoperative perfusion index measurements between groups. Arterial blood gas and lactate results will be obtained from routine clinical testing without an additional invasive procedure for research. Demographic characteristics, ASA physical status, anesthesia and surgical duration, perioperative temperature, and relevant intraoperative clinical variables will be recorded.

The primary outcome will be compared using one-way analysis of variance when distributional assumptions are met, or the Kruskal-Wallis test otherwise, with appropriate post-hoc comparisons. Repeated perfusion index measurements will also be examined for group and time effects. Secondary continuous and categorical outcomes will be analyzed with methods appropriate to their distributions. Associations of perfusion index with lactate, blood gas parameters, and pain scores will be examined using Pearson or Spearman correlation. Statistical significance will be set at p < 0.05.

The outcome assessor will be blinded to group assignment. Postoperative pain will be assessed using a 0-10 visual analogue scale at PACU admission and at 5 and 10 minutes. Wound infection will be assessed during the 14-day period following surgery.

Studientyp

Interventionell

Einschreibung (Geschätzt)

108

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Çiğdem Ünal Kantekin, MD
  • Telefonnummer: +90 505 443 3056
  • E-Mail: drcgdm@hotmail.com

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective colon resection surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • Age younger than 18 years.
  • Emergency surgery.
  • Severe vascular disease that may affect peripheral circulation, such as advanced peripheral arterial disease.
  • Severe cardiovascular instability.
  • Fever (>38 degrees Celsius) or hypothermia (<36 degrees Celsius) before surgery.
  • Severe anemia (hemoglobin <8 g/dL).
  • Requirement for vasopressor or inotropic support.
  • A condition in the measurement limb that prevents perfusion index measurement, such as severe peripheral edema, an intravenous line, or involvement of the surgical field.
  • Refusal to participate.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: 10-Minute Prewarming

Participants receive 10 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Experimental: 30-Minute Prewarming

Participants receive 30 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Kein Eingriff: Control: No Prewarming

Participants receive routine preoperative care without active prewarming before induction of general anesthesia. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Mean Postoperative Perfusion Index
Zeitfenster: At PACU admission and 5 and 10 minutes after admission

Perfusion index (PI) is measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission, 5 minutes, and 10 minutes. The primary outcome is the arithmetic mean of these three measurements. PI reflects the ratio of the pulsatile to nonpulsatile component of the photoplethysmographic signal and is used as an indicator of peripheral perfusion.

At PACU admission and 5 and 10 minutes after admission

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative Pleth Variability Index
Zeitfenster: At PACU admission and 5 and 10 minutes after admission

Pleth variability index (PVI) is measured noninvasively using a pulse oximeter at PACU admission, 5 minutes, and 10 minutes to compare early postoperative changes among the three study groups.

At PACU admission and 5 and 10 minutes after admission
Postoperative Arterial Lactate
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial lactate concentration, reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission. No additional arterial sampling is performed solely for this study.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial pH
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial pH obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Carbon Dioxide Partial Pressure
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial carbon dioxide partial pressure (PaCO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Oxygen Partial Pressure
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial oxygen partial pressure (PaO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Bicarbonate
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial bicarbonate concentration (HCO3), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Base Excess
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial base excess (BE), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Hemoglobin
Zeitfenster: At postanesthesia care unit (PACU) admission (0 minutes)

Hemoglobin concentration, reported in g/dL, recorded from routine blood gas testing at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Shivering
Zeitfenster: From PACU admission through the first 30 minutes after admission

Number of participants with postoperative shivering. Shivering is recorded as present or absent during the first 30 minutes after postanesthesia care unit (PACU) admission.

From PACU admission through the first 30 minutes after admission
Time to Initiation of Oral Feeding
Zeitfenster: From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery

Time from the end of surgery to the first initiation of oral feeding, recorded in hours. Participants are followed for initiation of oral feeding for up to 14 days after surgery.

From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery
Postoperative Pain Score
Zeitfenster: At PACU admission and 5 and 10 minutes after admission

Pain intensity assessed using a visual analogue scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Scores are recorded at PACU admission, 5 minutes, and 10 minutes. Higher scores indicate greater pain.

At PACU admission and 5 and 10 minutes after admission
Wound Infection Within 14 Days After Surgery
Zeitfenster: Within 14 days after surgery

Number of participants who develop a wound infection during the 14-day period following surgery. Wound infection is recorded as present or absent.

Within 14 days after surgery

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Çiğdem Ünal Kantekin, MD, Kayseri City Hospital

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

15. Oktober 2026

Primärer Abschluss (Geschätzt)

15. Februar 2027

Studienabschluss (Geschätzt)

15. März 2027

Studienanmeldedaten

Zuerst eingereicht

23. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

30. September 2026

Zuerst gepostet (Tatsächlich)

5. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

30. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • KCH-PREWARM-2026-1080

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified individual participant data collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

IPD-Sharing-Zeitrahmen

De-identified individual participant data will be available upon reasonable request beginning with publication of the primary results and continuing for 3 years after publication.

IPD-Sharing-Zugriffskriterien

Researchers may request de-identified participant-level data by contacting the principal investigator, Çiğdem Ünal Kantekin, at drcgdm@hotmail.com. Requests will be considered on a reasonable-request basis.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .